This new approach to genomic data will provide new insights to individuals for diseases such as cancers, epilepsy, diabetes, Alzheimer's, Parkinson's disease and other rare diseases. People in all countries will be able to benefit from Dante Labs AI.

Dante Labs launched Dante Labs Business, a new portal tailored for Healthcare Professionals and Researchers that combines the great genetics expertise of Dante Labs with the tailored needs of the private healthcare sector, academia and research.

Dante Labs introduced 30x long reads whole genome sequencing based on Oxford Nanopore technology. This is the first long reads whole genome available commercially worldwide. Sequencing will be performed at Dante Labs' new highly automated, certified third-generation sequencing center in L'Aquila, Italy.

Dante Labs introduced a new Whole Genome Sequencing of 130X coverage for the Exome and 30X coverage for DNA's non-coding regions